(Q33444727)

English

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

Europe PubMed Central

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

systematic review

1 reference

based on heuristic

inferred from title

Andrea Cipriani

object named as

Andrea Cipriani

4

0 references

object named as

Atsuo Nakagawa

3

0 references

5

object named as

Corrado Barbui

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

object named as

Hugh McGuire

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rachel Churchill

object named as

Rachel Churchill

7

1 reference

ORCID Public Data File 2021

Toshi A Furukawa

8

object named as

Toshi A Furukawa

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

object named as

Ichiro M Omori

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

object named as

Norio Watanabe

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

MANGA (Meta-Analysis of New Generation Antidepressants) Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

35-53

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

https://scigraph.springernature.com/pub.10.2165/11319480-000000000-00000

0 references

A consumer's guide to subgroup analyses

1 reference

https://api.crossref.org/works/10.2165%2F11319480-000000000-00000

21 January 2018

Confidence intervals for the number needed to treat

1 reference

https://api.crossref.org/works/10.2165%2F11319480-000000000-00000

21 January 2018

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading

1 reference

https://api.crossref.org/works/10.2165%2F11319480-000000000-00000

21 January 2018

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mirtazapine compared with paroxetine in major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between unreported outcomes and effect size estimates in Cochrane meta-analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of mirtazapine: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the pharmacological and clinical profile of mirtazapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety reporting in randomized trials of mental health interventions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of factors used by physicians and patients in the selection of antidepressant agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant-induced sexual dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20030418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11319480-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33444727&oldid=1858068444"